Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (8 quarters reported)
$281M in Q4 2021 → — now. Hover for any quarter.
As reported for the quarter ended September 30, 2023. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| N N/a | NaN% | Unchanged | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 7 quarters.
quarter ended September 30, 2023 · filed October 25, 2024
No position changes this quarter.
quarter ended June 30, 2023 · filed October 25, 2024
No position changes this quarter.
quarter ended March 31, 2023 · filed October 25, 2024
No position changes this quarter.
quarter ended December 31, 2022 · filed October 25, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Paragon 28 Inc | Exited | −8,385,972 | −$149M | — |
| N N/a | New | +0 | — | — |
quarter ended September 30, 2022 · filed October 25, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Paragon 28 Inc | Trimmed | −6,158,018 | −$110M | 100.0% |
| Optinose Inc | Exited | −12,500,000 | −$45.5M | — |
| Mdxhealth Sa | Exited | −916,666 | −$7.56M | — |
quarter ended June 30, 2022 · filed October 25, 2024
No position changes this quarter.
quarter ended March 31, 2022 · filed October 25, 2024
No position changes this quarter.
Loading...
